Serum levels of perfluoroalkyl acids (PFAAs) with isomer analysis and their associations with medical parameters in Chinese pregnant women

Environment International

Volumn 64, Issue , 2014, Pages 40-47

  Jiang, Weiwei ^a   Zhang, Yifeng ^a   Zhu, Lingyan ^a   Deng, Jimin ^b  

^a NANKAI UNIVERSITY   (China)

^b Maternity and Child Care Center   (China)

Author keywords

Isomers; Medical parameters; Perfluoroalkyl acids; Pregnant women

Indexed keywords

ELECTROCHEMICAL FLUORINATION; HUMAN HEALTH RISK ASSESSMENT; MEDICAL PARAMETERS; PERFLUORINATED CARBOXYLIC ACIDS; PERFLUOROALKYL ACIDS; PERFLUOROOCTANE SULFONATES; PREGNANT WOMAN; TRANSPLACENTAL TRANSFERS;

BODY FLUIDS; RISK ASSESSMENT;

ISOMERS;

CARBOXYLIC ACID; FUNCTIONAL GROUP; PERFLUORINATED CARBOXYLIC ACID; PERFLUOROALKYL ACID; PERFLUORODECANOIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

CONCENTRATION (COMPOSITION); CORRELATION; ELECTROCHEMISTRY; HEALTH RISK; PREGNANCY; SERUM; TOXICITY;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHINESE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FLUORINATION; GESTATIONAL AGE; HEALTH HAZARD; HUMAN; ISOMER; MEDICAL PARAMETERS; PLACENTAL TRANSFER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

CHINA;

ISOMERS; MEDICAL PARAMETERS; PERFLUOROALKYL ACIDS; PREGNANT WOMEN;

ALKANESULFONIC ACIDS; CAPRYLATES; CHINA; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; ISOMERISM; PREGNANCY; SERUM ALBUMIN;

EID: 84890843970     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2013.12.001     Document Type: Article

References (57)

1. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Perfluorooctanoic acid-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator-activated receptor-alpha. Toxicol Sci 2007, 98:571-581.
2. Andersen M.E., Butenhoff J.L., Chang S.-C., Farrar D.G., Kennedy G.L., Lau C., et al. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol Sci 2008, 102:3-14.
3. Beesoon S., Webster G.M., Shoeib M., Harner T., Benskin J.P., Martin J.W. Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ Health Perspect 2011, 119:1659-1664.
4. Benskin J.P., Bataineh M., Martin J.W. Simultaneous characterization of perfluoroalkyl carboxylate, sulfonate, and sulfonamide isomers by liquid chromatography-tandem mass spectrometry. Anal Chem 2007, 79:6455-6464.
5. Benskin J.P., De Silva A.O., Martin L.J., Arsenault G., McCrindle R., Riddell N., et al. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 1: single dose. Environ Toxicol Chem 2009, 28:542-554.
6. Benskin J.P., Holt A., Martin J.W. Isomer-specific biotransformation rates of a perfluorooctane sulfonate (PFOS)-precursor by cytochrome P450 isozymes and human liver microsomes. Environ Sci Technol 2009, 43:8566-8572.
7. Benskin J.P., De Silva A.O., Martin J.W. Isomer profiling of perfluorinated substances as a tool for source tracking: a review of early findings and future applications. Rev Environ Contam Toxicol 2010, 208:111-160.
8. Benskin J.P., Yeung L.W.Y., Yamashita N., Taniyasu S., Lam P.K.S., Martin J.W. Perfluorinated acid isomer profiling in water and quantitative assessment of manufacturing source. Environ Sci Technol 2010, 44:9049-9054.
9. Butenhoff J.L., Kennedy G.L., Chang S.-C., Olsen G.W. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012, 298:1-13.
10. De Silva A.O., Mabury S.A. Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 2006, 40:2903-2909.
11. De Silva A.O., Benskin J.P., Martin L.J., Arsenault G., McCrindle R., Riddell N., et al. Disposition of perfluorinated acid isomers in Sprague-Dawley rats; part 2: subchronic dose. Environ Toxicol Chem 2009, 28:555-567.
12. De Silva A.O., Tseng P., Mabury S. Toxicokinetics of perfluorocarboxylate isomers in rainbow trout. Environ Toxicol Chem 2009, 28:330-337.
13. DeWitt J.C., Shnyra A., Badr M.Z., Loveless S.E., Hoban D., Frame S.R., et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 2009, 39:76-94.
14. Emmett E.A., Zhang H., Shofer F.S., Freeman D., Rodway N.V., Desai C., et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med 2006, 48:771-779.
15. Fair P.A., Romano T., Schaefer A.M., Reif J.S., Bossart G.D., Houde M., et al. Associations between perfluoroalkyl compounds and immune and clinical chemistry parameters in highly exposed bottlenose dolphins (Tursiops truncatus). Environ Toxicol Chem 2013, 32:736-746.
16. Fromme H., Mosch C., Morovitz M., Alba-Alejandre I., Boehmer S., Kiranoglu M., et al. Pre- and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 2010, 44:7123-7129.
17. Gallo V., Leonardi G., Genser B., Lopez-Espinosa M.-J., Frisbee S.J., Karlsson L., et al. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ Health Perspect 2012, 120:655-660.
18. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., et al. Global suppression of il-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem 2004, 279:16154-16160.
19. Grandjean P., Andersen E.W., Budtz-Jorgensen E., Nielsen F., Molbak K., Weihe P., et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 2012, 307:391-397.
20. Hanssen L., Roellin H., Odland J.O., Moe M.K., Sandanger T.M. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J Environ Monit 2010, 12:1355-1361.
21. Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito N., Koizumi A. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 2005, 99:253-261.
22. Haug L.S., Thomsen C., Bechert G. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 2009, 43:2131-2136.
23. Haug L.S., Huber S., Becher G., Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds-comparing exposure estimates with biomarkers of exposure. Environ Int 2011, 37:687-693.
24. Hoff P.T., Van Dongen W., Esmans E.L., Blust R., De Coen W.M. Evaluation of the toxicological effects of perfluorooctane sulfonic acid in the common carp (Cyprinus carpio). Aquat Toxicol 2003, 62:349-359.
25. Hoff P.T., Van de Vijver K., Dauwe T., Covaci A., Maervoet J., Eens M., et al. Evaluation of biochemical effects related to perfluorooctane sulfonic acid exposure in organohalogen-contaminated great tit (Parus major) and blue tit (Parus caeruleus) nestlings. Chemosphere 2005, 61:1558-1569.
26. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C.G. Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 2006, 40:3463-3473.
27. Javins B., Hobbs G., Ducatman A.M., Pilkerton C., Tacker D., Knox S.S. Circulating maternal perfluoroalkyl substances during pregnancy in the C8 health study. Environ Sci Technol 2013, 47:1606-1613.
28. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 2004, 38:4489-4495.
29. Karrman A., Langlois I., van Bavel B., Lindstrom G., Oehme M. Identification and pattern of perfluorooctane sulfonate (PFOS) isomers in human serum and plasma. Environ Int 2007, 33:782-788.
30. Kato K., Wong L.-Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008. Environ Sci Technol 2011, 45:8037-8045.
31. Kim S.-K., Lee K.T., Kang C.S., Tao L., Kannan K., Kim K.-R., et al. Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. Environ Pollut 2011, 159:169-174.
32. Kuklenyik Z., Reich J.A., Tully J.S., Needham L.L., Calafat A.M. Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 2004, 38:3698-3704.
33. Liu J., Li J., Liu Y., Chan H.M., Zhao Y., Cai Z., et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int 2011, 37:1206-1212.
34. Lopez-Espinosa M.-J., Fletcher T., Armstrong B., Genser B., Dhatariya K., Mondal D., et al. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 2011, 45:8160-8166.
35. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., et al. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 2006, 220:203-217.
36. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 2008, 108:56-62.
37. O'Brien J.M., Kennedy S.W., Chu S., Letcher R.J. Isomer-specific accumulation of perfluorooctane sulfonate in the liver of chicken embryos exposed in ovo to a technical mixture. Environ Toxicol Chem 2011, 30:226-231.
38. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American red cross adult blood donors. Environ Health Perspect 2003, 111:1892-1901.
39. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007, 115:1298-1305.
40. Parsons J.R., Sáez M., Dolfing J., de Voogt P. Biodegradation of perfluorinated compounds. Rev Environ Contam Toxicol 2008, 196:53-71.
41. Paul A.G., Jones K.C., Sweetman A.J. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ Sci Technol 2008, 43:386-392.
42. Powley C.R., George S.W., Russell M.H., Hoke R.A., Buck R.C. Polyfluorinated chemicals in a spatially and temporally integrated food web in the western arctic. Chemosphere 2008, 70:664-672.
43. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006, 40:32-44.
44. Riddell N., Arsenault G., Benskin J.P., Chittim B., Martin J.W., McAlees A., et al. Branched perfluorooctane sulfonate isomer quantification and characterization in blood serum samples by HPLC/ESI-MS(/MS). Environ Sci Technol 2009, 43:7902-7908.
45. Ross M.S., Wong C.S., Martin J.W. Isomer-specific biotransformation of perfluorooctane sulfonamide in Sprague-Dawley rats. Environ Sci Technol 2012, 46:3196-3203.
46. Rylander C., Brustad M., Falk H., Sandanger T.M. Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway. J Environ Public Health 2009, 2009. 268219-268219.
47. Rylander C., Duong Trong P., Odland J.O., Sandanger T.M. Perfluorinated compounds in delivering women from south central Vietnam. J Environ Monit 2009, 11:2002-2008.
48. Shankar A., Xiao J., Ducatman A. Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am J Epidemiol 2011, 174:893-900.
49. Sharpe R.L., Benskin J.P., Laarman A.H., MacLeod S.L., Martin J.W., Wong C.S., et al. Perfluorooctane sulfonate toxicity, isomer-specific accumulation, and maternal transfer in zebrafish (Danio rerio) and rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 2010, 29:1957-1966.
50. Stein C.R., Wolff M.S., Calafat A.M., Kato K., Engel S.M. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study. Reprod Toxicol 2012, 34:312-316.
51. Thomsen C., Haug L.S., Stigum H., Froshaug M., Broadwell S.L., Becher G. Changes in concentrations of perfluorinated compounds, polybrominated biphenyl ethers, and polychlorinated biphenyls in Norwegian breast-milk during twelve months of lactation. Environ Sci Technol 2010, 44:9550-9556.
52. Vestergren R., Cousins I.T., Trudel D., Wormuth M., Scheringer M. Estimating the contribution of precursor compounds in consumer exposure to PFOS and PFOA. Chemosphere 2008, 73:1617-1624.
53. Wang T., Wang Y., Liao C., Cai Y., Jiang G. Perspectives on the inclusion of perfluorooctane sulfonate into the Stockholm convention on persistent organic pollutants. Environ Sci Technol 2009, 43:5171-5175.
54. Wang M., Park J.-S., Petreas M. Temporal changes in the levels of perfluorinated compounds in California women's serum over the past 50years. Environ Sci Technol 2011, 45:7510-7516.
55. Xie S., Wang T., Liu S., Jones K.C., Sweetman A.J., Lu Y. Industrial source identification and emission estimation of perfluorooctane sulfonate in China. Environ Int 2013, 52:1-8.
56. Yahia D., Abd El-Nasser M., Abedel-Latif M., Tsukuba C., Yoshida M., Sato I., et al. Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction. J Toxicol Sci 2010, 35:527-533.
57. Zhang Y., Beesoon S., Zhu L., Martin J.W. Isomers of perfluorooctanesulfonate and perfluorooctanoate and total perfluoroalkyl acids in human serum from two cities in north China. Environ Int 2013, 53:9-17.